Differing endoplasmic reticulum stress response to excess lipogenesis versus lipid oversupply in relation to hepatic steatosis and insulin resistance

PLoS ONE

Volumn 7, Issue 2, 2012, Pages

  Ren, Lu Ping ^a,b   Chan, Stanley M H ^a   Zeng, Xiao Yi ^a,b   Laybutt, D Ross ^b   Iseli, Tristan J ^b   Sun, Ruo Qiong ^a   Kraegen, Edward W ^b,c   Cooney, Gregory J ^b,c   Turner, Nigel ^b,c   Ye, Ji Ming ^a,b  

^a RMIT UNIVERSITY   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYACYL COENZYME A DEHYDROGENASE; ACETYL COENZYME A CARBOXYLASE; ACYL COENZYME A DESATURASE; CARNITINE PALMITOYLTRANSFERASE I; CITRATE SYNTHASE; FATTY ACID SYNTHASE; GLUTATHIONE; GLYCOGEN SYNTHASE KINASE 3BETA; I KAPPA B KINASE; INITIATION FACTOR 2ALPHA; MESSENGER RNA; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA COACTIVATOR 1ALPHA; PROTEIN IRE1; PROTEIN KINASE B; PROTEIN PERK; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; STRESS ACTIVATED PROTEIN KINASE; TRIACYLGLYCEROL; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1; FRUCTOSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARBOHYDRATE DIET; CONTROLLED STUDY; ENDOPLASMIC RETICULUM STRESS; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FATTY LIVER; FEEDING; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; LIPID DIET; LIPID METABOLISM; LIPID OVERSUPPLY; LIPOGENESIS; MALE; MITOCHONDRION; MOUSE; NONHUMAN; OXIDATIVE STRESS; PATHOGENESIS; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ADIPOGENESIS; ANIMAL; C57BL MOUSE; FAT INTAKE; LIVER; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; PHYSIOLOGY;

MUS;

ADIPOGENESIS; ANIMALS; BLOTTING, WESTERN; DIETARY FATS; ENDOPLASMIC RETICULUM STRESS; FATTY LIVER; FRUCTOSE; GLUCOSE INTOLERANCE; INSULIN RESISTANCE; LIPID METABOLISM; LIPOGENESIS; LIVER; MALE; MICE; MICE, INBRED C57BL; MITOCHONDRIA; OXIDATIVE STRESS;

EID: 84857082948     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0030816     Document Type: Article

References (61)

1. Denechaud PD, Bossard P, Lobaccaro JM, Millatt L, Staels B, et al. (2008) ChREBP, but not LXRs, is required for the induction of glucose-regulated genes in mouse liver. J Clin Invest 118: 956-964.
2. Fabbrini E, Sullivan S, Klein S, (2010) Obesity and nonalcoholic fatty liver disease: biochemical, metabolic, and clinical implications. Hepatology 51: 679-689.
3. Cortez-Pinto H, de Moura MC, Day CP, (2006) Non-alcoholic steatohepatitis: from cell biology to clinical practice. J Hepatol 44: 197-208.
4. Stanhope KL, Schwarz JM, Keim NL, Griffen SC, Bremer AA, et al. (2009) Consuming fructose-sweetened, not glucose-sweetened, beverages increases visceral adiposity and lipids and decreases insulin sensitivity in overweight/obese humans. J Clin Invest 119: 1322-1334.
5. Lim JS, Mietus-Snyder M, Valente A, Schwarz JM, Lustig RH, (2010) The role of fructose in the pathogenesis of NAFLD and the metabolic syndrome. Nat Rev Gastroenterol Hepatol.
6. Hegarty BD, Furler SM, Ye J, Cooney GJ, Kraegen EW, (2003) The role of intramuscular lipid in insulin resistance. Acta Physiol Scand 178: 373-383.
7. Erion DM, Shulman GI, (2010) Diacylglycerol-mediated insulin resistance. Nat Med 16: 400-402.
8. Kraegen EW, Clark PW, Jenkins AB, Daley EA, Chisholm DJ, et al. (1991) Development of muscle insulin resistance after liver insulin resistance in high-fat-fed rats. Diabetes 40: 1397-1403.
9. Petersen KF, Dufour S, Befroy D, Garcia R, Shulman GI, (2004) Impaired mitochondrial activity in the insulin-resistant offspring of patients with type 2 diabetes. N Engl J Med 350: 664-671.
10. Ibdah JA, Perlegas P, Zhao Y, Angdisen J, Borgerink H, et al. (2005) Mice heterozygous for a defect in mitochondrial trifunctional protein develop hepatic steatosis and insulin resistance. Gastroenterology 128: 1381-1390.
11. Rector RS, Thyfault JP, Uptergrove GM, Morris EM, Naples SP, et al. (2010) Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol 52: 727-736.
12. Turner N, Bruce CR, Beale SM, Hoehn KL, So T, et al. (2007) Excess lipid availability increases mitochondrial fatty acid oxidative capacity in muscle: evidence against a role for reduced fatty acid oxidation in lipid-induced insulin resistance in rodents. Diabetes 56: 2085-2092.
13. Ozcan U, Yilmaz E, Ozcan L, Furuhashi M, Vaillancourt E, et al. (2006) Chemical chaperones reduce ER stress and restore glucose homeostasis in a mouse model of type 2 diabetes. Science 313: 1137-1140.
14. Lee AH, Glimcher LH, (2009) Intersection of the unfolded protein response and hepatic lipid metabolism. Cell Mol Life Sci 66: 2835-2850.
15. Hotamisligil GS, (2010) Endoplasmic reticulum stress and the inflammatory basis of metabolic disease. Cell 140: 900-917.
16. Ozcan U, Cao Q, Yilmaz E, Lee AH, Iwakoshi NN, et al. (2004) Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes. Science 306: 457-461.
17. Lee AH, Scapa EF, Cohen DE, Glimcher LH, (2008) Regulation of hepatic lipogenesis by the transcription factor XBP1. Science 320: 1492-1496.
18. Savage DB, Choi CS, Samuel VT, Liu ZX, Zhang D, et al. (2006) Reversal of diet-induced hepatic steatosis and hepatic insulin resistance by antisense oligonucleotide inhibitors of acetyl-CoA carboxylases 1 and 2. J Clin Invest 116: 817-824.
19. Thorburn AW, Storlien LH, Jenkins AB, Khouri S, Kraegen EW, (1989) Fructose-induced in vivo insulin resistance and elevated plasma triglyceride levels in rats. Am J Clin Nutr 49: 1155-1163.
20. Selva DM, Hogeveen KN, Innis SM, Hammond GL, (2007) Monosaccharide-induced lipogenesis regulates the human hepatic sex hormone-binding globulin gene. J Clin Invest 117: 3979-3987.
21. Ye JM, Iglesias MA, Watson DG, Ellis B, Wood L, et al. (2003) PPARalpha/gamma ragaglitazar eliminates fatty liver and enhances insulin action in fat-fed rats in the absence of hepatomegaly. Am J Physiol Endocrinol Metab 284: E531-540.
22. Tan MJ, Ye JM, Turner N, Hohnen-Behrens C, Ke CQ, et al. (2008) Antidiabetic activities of triterpenoids isolated from bitter melon associated with activation of the AMPK pathway. Chem Biol 15: 263-273.
23. Turner N, Hariharan K, TidAng J, Frangioudakis G, Beale SM, et al. (2009) Enhancement of muscle mitochondrial oxidative capacity and alterations in insulin action are lipid species dependent: potent tissue-specific effects of medium-chain fatty acids. Diabetes 58: 2547-2554.
24. Dietschy JM, Spady DK, (1984) Measurement of rates of cholesterol synthesis using tritiated water. J Lipid Res 25: 1469-1476.
25. Molero JC, Waring SG, Cooper A, Turner N, Laybutt R, et al. (2006) Casitas b-lineage lymphoma-deficient mice are protected against high-fat diet-induced obesity and insulin resistance. Diabetes 55: 708-715.
26. Djouadi F, Riveau B, Merlet-Benichou C, Bastin J, (1997) Tissue-specific regulation of medium-chain acyl-CoA dehydrogenase gene by thyroid hormones in the developing rat. Biochem J 324 (Pt 1): 289-294.
27. Woodman OL, Malakul W, (2009) 3′,4′-Dihydroxyflavonol prevents diabetes-induced endothelial dysfunction in rat aorta. Life Sci 85: 54-59.
28. Dentin R, Benhamed F, Pegorier JP, Foufelle F, Viollet B, et al. (2005) Polyunsaturated fatty acids suppress glycolytic and lipogenic genes through the inhibition of ChREBP nuclear protein translocation. J Clin Invest 115: 2843-2854.
29. Kammoun HL, Chabanon H, Hainault I, Luquet S, Magnan C, et al. (2009) GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice. J Clin Invest 119: 1201-1215.
30. Shimano H, Horton JD, Shimomura I, Hammer RE, Brown MS, et al. (1997) Isoform 1c of sterol regulatory element binding protein is less active than isoform 1a in livers of transgenic mice and in cultured cells. J Clin Invest 99: 846-854.
31. Hiller S, Wagner G, (2009) The role of solution NMR in the structure determinations of VDAC-1 and other membrane proteins. Curr Opin Struct Biol 19: 396-401.
32. Sastre J, Serviddio G, Pereda J, Minana JB, Arduini A, et al. (2007) Mitochondrial function in liver disease. Front Biosci 12: 1200-1209.
33. Garcia-Ruiz C, Fernandez-Checa JC, (2006) Mitochondrial glutathione: hepatocellular survival-death switch. J Gastroenterol Hepatol 21 (Suppl 3): S3-6.
34. Nagai Y, Yonemitsu S, Erion DM, Iwasaki T, Stark R, et al. (2009) The role of peroxisome proliferator-activated receptor gamma coactivator-1 beta in the pathogenesis of fructose-induced insulin resistance. Cell Metab 9: 252-264.
35. Denechaud PD, Dentin R, Girard J, Postic C, (2008) Role of ChREBP in hepatic steatosis and insulin resistance. FEBS Lett 582: 68-73.
36. Dentin R, Girard J, Postic C, (2005) Carbohydrate responsive element binding protein (ChREBP) and sterol regulatory element binding protein-1c (SREBP-1c): two key regulators of glucose metabolism and lipid synthesis in liver. Biochimie 87: 81-86.
37. Koo HY, Wallig MA, Chung BH, Nara TY, Cho BH, et al. (2008) Dietary fructose induces a wide range of genes with distinct shift in carbohydrate and lipid metabolism in fed and fasted rat liver. Biochim Biophys Acta 1782: 341-348.
38. Rodriguez-Calvo R, Barroso E, Serrano L, Coll T, Sanchez RM, et al. (2009) Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A. Hepatology 49: 106-115.
39. Koo HY, Miyashita M, Cho BH, Nakamura MT, (2009) Replacing dietary glucose with fructose increases ChREBP activity and SREBP-1 protein in rat liver nucleus. Biochem Biophys Res Commun 390: 285-289.
40. Kim S, Sohn I, Ahn JI, Lee KH, Lee YS, et al. (2004) Hepatic gene expression profiles in a long-term high-fat diet-induced obesity mouse model. Gene 340: 99-109.
41. Dobrosotskaya IY, Seegmiller AC, Brown MS, Goldstein JL, Rawson RB, (2002) Regulation of SREBP processing and membrane lipid production by phospholipids in Drosophila. Science 296: 879-883.
42. Perez-Carreras M, Del Hoyo P, Martin MA, Rubio JC, Martin A, et al. (2003) Defective hepatic mitochondrial respiratory chain in patients with nonalcoholic steatohepatitis. Hepatology 38: 999-1007.
43. Satapati S, He T, Inagaki T, Potthoff M, Merritt ME, et al. (2008) Partial resistance to peroxisome proliferator-activated receptor-alpha agonists in ZDF rats is associated with defective hepatic mitochondrial metabolism. Diabetes 57: 2012-2021.
44. Collison KS, Saleh SM, Bakheet RH, Al-Rabiah RK, Inglis AL, et al. (2009) Diabetes of the liver: the link between nonalcoholic fatty liver disease and HFCS-55. Obesity (Silver Spring) 17: 2003-2013.
45. Turner N, Li JY, Gosby A, To SW, Cheng Z, et al. (2008) Berberine and its more biologically available derivative, dihydroberberine, inhibit mitochondrial respiratory complex I: a mechanism for the action of berberine to activate AMP-activated protein kinase and improve insulin action. Diabetes 57: 1414-1418.
46. Mantena SK, Vaughn DP, Andringa KK, Eccleston HB, King AL, et al. (2009) High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function in vivo. Biochem J 417: 183-193.
47. Ahmad FK, He Z, King GL, (2005) Molecular targets of diabetic cardiovascular complications. Curr Drug Targets 6: 487-494.
48. Brownlee M, (2001) Biochemistry and molecular cell biology of diabetic complications. Nature 414: 813-820.
49. Videla LA, Rodrigo R, Orellana M, Fernandez V, Tapia G, et al. (2004) Oxidative stress-related parameters in the liver of non-alcoholic fatty liver disease patients. Clin Sci (Lond) 106: 261-268.
50. Spolarics Z, Meyenhofer M, (2000) Augmented resistance to oxidative stress in fatty rat livers induced by a short-term sucrose-rich diet. Biochim Biophys Acta 1487: 190-200.
51. Gawrieh S, Opara EC, Koch TR, (2004) Oxidative stress in nonalcoholic fatty liver disease: pathogenesis and antioxidant therapies. J Investig Med 52: 506-514.
52. Perlemuter G, Davit-Spraul A, Cosson C, Conti M, Bigorgne A, et al. (2005) Increase in liver antioxidant enzyme activities in non-alcoholic fatty liver disease. Liver Int 25: 946-953.
53. Verna EC, Berk PD, (2008) Role of fatty acids in the pathogenesis of obesity and fatty liver: impact of bariatric surgery. Semin Liver Dis 28: 407-426.
54. Holland WL, Miller RA, Wang ZV, Sun K, Barth BM, et al. (2011) Receptor-mediated activation of ceramidase activity initiates the pleiotropic actions of adiponectin. Nat Med 17: 55-63.
55. Vila L, Roglans N, Alegret M, Sanchez RM, Vazquez-Carrera M, et al. (2008) Suppressor of cytokine signaling-3 (SOCS-3) and a deficit of serine/threonine (Ser/Thr) phosphoproteins involved in leptin transduction mediate the effect of fructose on rat liver lipid metabolism. Hepatology 48: 1506-1516.
56. Wierzbicki M, Chabowski A, Zendzian-Piotrowska M, Harasim E, Gorski J, (2009) Chronic, in vivo, PPARalpha activation prevents lipid overload in rat liver induced by high fat feeding. Adv Med Sci 54: 59-65.
57. Ryu D, Seo WY, Yoon YS, Kim YN, Kim SS, et al. (2011) Endoplasmic reticulum stress promotes LIPIN2-dependent hepatic insulin resistance. Diabetes 60: 1072-1081.
58. Gorden DL, Ivanova PT, Myers DS, McIntyre JO, VanSaun MN, et al. (2011) Increased diacylglycerols characterize hepatic lipid changes in progression of human nonalcoholic fatty liver disease; comparison to a murine model. PLoS One 6: e22775.
59. Idris I, Gray S, Donnelly R, (2001) Protein kinase C activation: isozyme-specific effects on metabolism and cardiovascular complications in diabetes. Diabetologia 44: 659-673.
60. Winnay JN, Boucher J, Mori MA, Ueki K, Kahn CR, (2010) A regulatory subunit of phosphoinositide 3-kinase increases the nuclear accumulation of X-box-binding protein-1 to modulate the unfolded protein response. Nat Med 16: 438-445.
61. Park SW, Zhou Y, Lee J, Lu A, Sun C, et al. (2010) The regulatory subunits of PI3K, p85alpha and p85beta, interact with XBP-1 and increase its nuclear translocation. Nat Med 16: 429-437.